116 related articles for article (PubMed ID: 38458037)
41. Nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: clinical outcomes and patterns of failure among subsets of 8th AJCC stage IVa.
Huang CL; Guo R; Li JY; Xu C; Mao YP; Tian L; Lin AH; Sun Y; Ma J; Tang LL
Eur Radiol; 2020 Feb; 30(2):816-822. PubMed ID: 31650266
[TBL] [Abstract][Full Text] [Related]
42. The Largest Known Survival Analysis of Patients with Brain Metastasis from Thyroid Cancer Based on Prognostic Groups.
Choi J; Kim JW; Keum YS; Lee IJ
PLoS One; 2016; 11(4):e0154739. PubMed ID: 27128487
[TBL] [Abstract][Full Text] [Related]
43. A retrospective study of 606 cases of nasopharyngeal carcinoma with or without oropharyngeal candidiasis during radiotherapy.
Qiu WZ; Ke LR; Xia WX; Yang J; Yu YH; Liang H; Huang XJ; Liu GY; Li WZ; Xiang YQ; Guo X; Lv X
PLoS One; 2017; 12(8):e0182963. PubMed ID: 28797119
[TBL] [Abstract][Full Text] [Related]
44. Brain Metastases From Differentiated Thyroid Carcinoma: A Retrospective Study of 22 Patients.
Wu T; Jiao Z; Li Y; Peng J; Yao F; Chen W; Yang A
Front Endocrinol (Lausanne); 2021; 12():730025. PubMed ID: 34603207
[TBL] [Abstract][Full Text] [Related]
45. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis.
Liu N; Chen NY; Cui RX; Li WF; Li Y; Wei RR; Zhang MY; Sun Y; Huang BJ; Chen M; He QM; Jiang N; Chen L; Cho WC; Yun JP; Zeng J; Liu LZ; Li L; Guo Y; Wang HY; Ma J
Lancet Oncol; 2012 Jun; 13(6):633-41. PubMed ID: 22560814
[TBL] [Abstract][Full Text] [Related]
46. MRI-detected residual retropharyngeal lymph node after intensity-modulated radiotherapy in nasopharyngeal carcinoma: Prognostic value and a nomogram for the pretherapy prediction of it.
Li WZ; Liu GY; Lin LF; Lv SH; Qiang MY; Lv X; Wu YS; Liang H; Ke LR; Wang DL; Yu YH; Qiu WZ; Liu KY; Guo X; Li JP; Zou YJ; Xiang YQ; Xia WX
Radiother Oncol; 2020 Apr; 145():101-108. PubMed ID: 31931288
[TBL] [Abstract][Full Text] [Related]
47. Endoscopic surgery compared with intensity-modulated radiotherapy in resectable locally recurrent nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial.
Liu YP; Wen YH; Tang J; Wei Y; You R; Zhu XL; Li J; Chen L; Ling L; Zhang N; Zou X; Hua YJ; Chen YM; Chen L; Lu LX; Chen MY; Wen WP
Lancet Oncol; 2021 Mar; 22(3):381-390. PubMed ID: 33600761
[TBL] [Abstract][Full Text] [Related]
48. Radiation-induced cancer after treatment for nasopharyngeal carcinoma: a study from a high prevalence area.
Cao X; Wang C; Lin ZC; Lyu X
Rhinology; 2023 Feb; 61(1):77-84. PubMed ID: 36527736
[TBL] [Abstract][Full Text] [Related]
49. [The effect of overall treatment time on local control in nasopharyngeal carcinoma patients treated with intensity modulated radiation therapy].
Su SF; Han F; Zhao C; Chen CY; Xiao WW; Li JX; Lu TX
Zhonghua Yi Xue Za Zhi; 2011 Feb; 91(7):469-72. PubMed ID: 21418978
[TBL] [Abstract][Full Text] [Related]
50. Establishment and Validation of a Nomogram for Nasopharyngeal Carcinoma Patients Concerning the Prognostic Effect of Parotid Lymph Node Metastases.
Lin C; Sun XS; Liu SL; Li XY; Lu N; Li XL; Tang LQ; Guo L
Cancer Res Treat; 2020 Jul; 52(3):855-866. PubMed ID: 32164051
[TBL] [Abstract][Full Text] [Related]
51. Hyperfractionation compared with standard fractionation in intensity-modulated radiotherapy for patients with locally advanced recurrent nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial.
You R; Liu YP; Xie YL; Lin C; Duan CY; Chen DP; Pan Y; Qi B; Zou X; Guo L; Cao JY; Zhang YN; Wang ZQ; Liu YL; Ouyang YF; Wen K; Yang Q; Xie RQ; Li HF; Duan XT; Ding X; Peng L; Chen SY; Liang JL; Feng ZK; Xia TL; Xie RL; Jiang R; Gu CM; Liu RZ; Sun R; Yang X; Liu LZ; Ling L; Liu Q; Ng WT; Hua YJ; Huang PY; Chen MY
Lancet; 2023 Mar; 401(10380):917-927. PubMed ID: 36842439
[TBL] [Abstract][Full Text] [Related]
52. Pretreatment MRI radiomics analysis allows for reliable prediction of local recurrence in non-metastatic T4 nasopharyngeal carcinoma.
Zhang LL; Huang MY; Li Y; Liang JH; Gao TS; Deng B; Yao JJ; Lin L; Chen FP; Huang XD; Kou J; Li CF; Xie CM; Lu Y; Sun Y
EBioMedicine; 2019 Apr; 42():270-280. PubMed ID: 30928358
[TBL] [Abstract][Full Text] [Related]
53. Taxane/gemcitabine-containing chemotherapy plus locoregional IMRT for patients with de novo metastatic nasopharyngeal carcinoma: the treatment outcomes and prognostic factors analysis.
Du C; Ni M; Jiang J; Kong F; Zhai R; Lv Y; Hu C; Ying H
Eur Arch Otorhinolaryngol; 2022 Aug; 279(8):3947-3956. PubMed ID: 34981158
[TBL] [Abstract][Full Text] [Related]
54. Distribution pattern and prognosis of metastatic lymph nodes in cervical posterior to level V in nasopharyngeal carcinoma patients.
Jiang C; Gao H; Zhang L; Li H; Zhang T; Ma J; Liu B
BMC Cancer; 2020 Jul; 20(1):667. PubMed ID: 32680466
[TBL] [Abstract][Full Text] [Related]
55. Geographical disparities in the prognosis of patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy: a large institution-based cohort study from an endemic area.
Lin ST; Meng DF; Yang Q; Wang W; Peng LX; Zheng LS; Qiang YY; Mei Y; Xu L; Li CZ; Peng XS; Hu H; Lang YH; Liu ZJ; Wang MD; Li HF; Huang BJ; Qian CN; Sun R
BMJ Open; 2020 Nov; 10(11):e037150. PubMed ID: 33172940
[TBL] [Abstract][Full Text] [Related]
56. Continuous fall in hemoglobin level is a poor prognostic factor in patients with nasopharyngeal carcinoma treated with radiotherapy.
Gao J; Hu JY; Xia YF; Yi W; Tao YL; Li G
Chin J Cancer; 2010 May; 29(5):561-6. PubMed ID: 20426909
[TBL] [Abstract][Full Text] [Related]
57. A new prognostic histopathologic classification of nasopharyngeal carcinoma.
Wang HY; Chang YL; To KF; Hwang JS; Mai HQ; Feng YF; Chang ET; Wang CP; Kam MK; Cheah SL; Lee M; Gao L; Zhang HZ; He JH; Jiang H; Ma PQ; Zhu XD; Zeng L; Chen CY; Chen G; Huang MY; Fu S; Shao Q; Han AJ; Li HG; Shao CK; Huang PY; Qian CN; Lu TX; Li JT; Ye W; Ernberg I; Ng HK; Wee JT; Zeng YX; Adami HO; Chan AT; Shao JY
Chin J Cancer; 2016 May; 35():41. PubMed ID: 27146632
[TBL] [Abstract][Full Text] [Related]
58. Clinical treatment considerations in the intensity-modulated radiotherapy era for parotid lymph node metastasis in patients with nasopharyngeal carcinoma.
Lin C; Lu N; Liang JL; Guo J; Gu LW; Sun R; Guo L; Yang Q
Radiother Oncol; 2023 Sep; 186():109802. PubMed ID: 37423477
[TBL] [Abstract][Full Text] [Related]
59. Second primary squamous cell carcinoma in patients with nasopharyngeal carcinoma after radiotherapy-Predictors and prognostic factors.
Wang X; Li Y; Gao Y; Ouyang D; Guo Z
Head Neck; 2018 Jul; 40(7):1434-1442. PubMed ID: 29522261
[TBL] [Abstract][Full Text] [Related]
60. Prognostic analysis of 152 patients with distant metastasis after intensity-modulated radiotherapy for nasopharyngeal carcinoma.
Yang H; Liu C; Luo S; Ma R; Zhou Y; Yin Y; Zhao L; Shi M
Ann Palliat Med; 2021 Jun; 10(6):6824-6832. PubMed ID: 34154349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
